SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Core Laboratories NV – ‘8-K’ for 1/15/21 – ‘EX-99.1’

On:  Friday, 1/15/21, at 4:10pm ET   ·   For:  1/15/21   ·   Accession #:  1564590-21-1332   ·   File #:  1-14273

Previous ‘8-K’:  ‘8-K’ on / for 12/17/20   ·   Next:  ‘8-K’ on / for 1/27/21   ·   Latest:  ‘8-K’ on / for 4/26/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/15/21  Core Laboratories NV              8-K:7,9     1/15/21   11:189K                                   ActiveDisclosure/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     34K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     11K 
 7: R1          Document and Entity Information                     HTML     49K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- clb-8k_20210115_htm                 XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- clb-20210115_lab                      XML     60K 
 5: EX-101.PRE  XBRL Presentations -- clb-20210115_pre               XML     36K 
 3: EX-101.SCH  XBRL Schema -- clb-20210115                          XSD     18K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               13±    20K 
11: ZIP         XBRL Zipped Folder -- 0001564590-21-001332-xbrl      Zip     12K 


‘EX-99.1’   —   Miscellaneous Exhibit


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

Exhibit 99.1

 

 

 

 

FOR IMMEDIATE RELEASE

 

CORE LAB ANNOUNCES Q1 2021 QUARTERLY DIVIDEND

AMSTERDAM (15 January 2021) - The Board of Supervisory Directors of Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam Exchange: "CLB NA") has announced a cash dividend of $0.01 per share of common stock payable in the first quarter of 2021. This first quarter dividend would mean a total payout of $0.04 per share of common stock, if maintained for the entire year. The quarterly $0.01 per share cash dividend will be payable on Tuesday, 16 February 2021, to shareholders of record on Monday, 25 January 2021. Dutch withholding tax will be deducted from the dividend at a rate of 15%.

 

Any determination to declare a future quarterly cash dividend, as well as the amount of any such cash dividend that may be declared, will be based on the Company's financial position, earnings, earnings outlook, capital expenditure plans, ongoing share repurchases, potential acquisition opportunities, and other relevant factors at the time.

 

The Company has scheduled a conference call to discuss Core's fourth quarter 2020 earnings. The call will begin at 7:30 a.m. CST / 2:30 p.m. CET on Thursday, 28 January 2021. To listen to the call, please go to Core's website at www.corelab.com .

 

Core Laboratories N.V. (www.corelab.com) is a leading provider of proprietary and patented reservoir description and production enhancement services used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world.

 

This release, as well as other statements we make, includes forward-looking statements regarding the future revenue, profitability, business strategies and developments of the Company made in reliance upon the safe harbor provisions of Federal securities law.  The Company's outlook is subject to various important cautionary factors, including risks and uncertainties related to the oil and natural gas industry, business conditions, international markets, international political climates, public health crises, such as the COVID-19 pandemic, and any related actions taken by businesses and governments, and other factors as more fully described in the Company's most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission.  These important factors could cause the Company's actual results to differ materially from those described in these forward-looking statements. Such statements are based on current expectations of the Company's performance and are subject to a variety of factors, some of which are not under the control of the Company.  Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company's future performance.  The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.

 

Visit the Company's website at www.corelab.com. Connect with Core Lab on Facebook, LinkedIn and YouTube.

 

For more information contact:

 


Exhibit 99.1

 

Gwen Y. Schreffler – SVP Corporate Development and Investor Relations, +1 713 328 6210

investor.relations@corelab.com

###

 

Top
Filing Submission 0001564590-21-001332   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 11:43:36.1am ET